Pharma Sector Faces Volatile Quarter Amid GST Impact and Weak US Generics
Pharma Sector Faces Volatile Quarter Amid GST Impact and Weak US Generics The article reports that the pharmaceutical sector is navigating a highly volatile quarter, influenced by dual pressures from domestic tax adjustments and persistent weakness in the critical US generics market. Key Factors Causing Volatility Domestic GST Impact: The implementation of Goods and Services… Read More »